ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05033	Nicotine addiction	4/67	56/7206	0.0017437110086
ko04012	ErbB signaling pathway	5/67	109/7206	0.00331289780864
ko04727	GABAergic synapse	5/67	110/7206	0.0034460366704
ko05032	Morphine addiction	5/67	110/7206	0.0034460366704
ko04666	Fc gamma R-mediated phagocytosis	5/67	122/7206	0.00535892145637
ko05231	Choline metabolism in cancer	5/67	134/7206	0.00792618995814
ko04080	Neuroactive ligand-receptor interaction	9/67	423/7206	0.0156836425585
ko01521	EGFR tyrosine kinase inhibitor resistance	4/67	106/7206	0.0166913504605
ko05215	Prostate cancer	4/67	111/7206	0.0194435951436
ko05213	Endometrial cancer	3/67	62/7206	0.0196693871184
ko05223	Non-small cell lung cancer	3/67	66/7206	0.0231844237636
ko05162	Measles	4/67	120/7206	0.0250730465226
ko04660	T cell receptor signaling pathway	4/67	124/7206	0.0278607007211
ko04728	Dopaminergic synapse	5/67	185/7206	0.0283147828921
ko00512	Mucin type O-glycan biosynthesis	2/67	29/7206	0.0294226342126
ko04915	Estrogen signaling pathway	4/67	131/7206	0.0331707440144
ko04320	Dorso-ventral axis formation	2/67	31/7206	0.0333015700977
ko04664	Fc epsilon RI signaling pathway	3/67	77/7206	0.03449707231
ko04923	Regulation of lipolysis in adipocytes	3/67	77/7206	0.03449707231
ko05214	Glioma	3/67	79/7206	0.0368113698698
ko04062	Chemokine signaling pathway	5/67	201/7206	0.0384781268347
ko05230	Central carbon metabolism in cancer	3/67	81/7206	0.0392039002656
ko05212	Pancreatic cancer	3/67	83/7206	0.0416741258351
ko05218	Melanoma	3/67	85/7206	0.0442214476422
ko04213	Longevity regulating pathway - multiple species	3/67	86/7206	0.0455238165279
ko05210	Colorectal cancer	3/67	86/7206	0.0455238165279
ko04917	Prolactin signaling pathway	3/67	87/7206	0.0468452087798
ko04662	B cell receptor signaling pathway	3/67	88/7206	0.0481855337475